• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TriSalus Life Sciences, Inc. - Common Stock (NQ:TLSI)

3.630 -0.270 (-6.92%)
Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 253,522
Open 3.830
Bid (Size) 2.280 (10,000)
Ask (Size) 4.000 (1,300)
Prev. Close 3.900
Today's Range 3.580 - 3.900
52wk Range 2.200 - 7.950
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Unusual volume stocks in Thursday's session ↗
September 24, 2026
Via Chartmill
These stocks are moving in today's after hours session ↗
September 22, 2026
Via Chartmill

Performance

52-Week Range 54.3% below 52-week high
3.630
2.2052W Low 7.9552W High
1 Week 12.5% below 1-week high
3.581W Low 4.151W High

TriSalus Life Sciences, Inc. - Common Stock (TLSI) traded between $2.20 and $7.95 over the past 52 weeks and last traded at $3.63, 54.3% below its 52-week high. Over the past week it ranged between $3.58 and $4.15.

Past 12 Months
-12.3%
-26.4%
-15.4%
-21.9%
-40.5%
-23.6%
1W -$0.51
1M -$1.30
3M -$0.66
6M -$1.02
YTD -$2.47
1Y -$1.12

TLSI was -23.6% over the past year, -21.9% over six months, -40.5% year to date, -12.3% in the last week.

12 Months vs Market
TLSI
-23.6%
DIA
+13.0%
SPY
+15.5%
QQQ
+18.3%
IWM
+10.4%

Over the past 12 months TLSI returned -23.6% versus DIA (Dow) +13.0%, SPY (S&P 500) +15.5%, QQQ (Nasdaq 100) +18.3% and IWM (Russell 2000) +10.4%.

Volume & Liquidity 0.94× 3-mo avg
Today 253,522 3-mo avg 268.9K
1W
157.1K
1M
459.1K
3M
268.9K
6M
372.4K
YTD
301.8K
1Y
272.3K

TLSI most recently traded 253,522 shares against a 3-month average daily volume of 268.9K.

More News

Read More
News headline image
TriSalus Life Sciences Receives FDA Clearance for TriNav® Advance, Strengthening Comprehensive Pressure-Enabled Drug Delivery™ (PEDD™) Portfolio for Liver Embolization
September 22, 2026
From TriSalus Life Sciences
Via Business Wire
News headline image
TriSalus Life Sciences to Participate in the H.C. Wainwright & Company 28th Annual Global Investment Conference
August 31, 2026
From TriSalus Life Sciences
Via Business Wire
News headline image
TriSalus Highlights Tumor-Treatment Expansion, FDA Catalyst at Growth Conference ↗
August 18, 2026
Via MarketBeat
News headline image
TriSalus Life Sciences Q2 Earnings Call Highlights ↗
August 07, 2026
Via MarketBeat
Topics Earnings
News headline image
TriSalus Life Sciences Reports Second Quarter 2026 Results
August 06, 2026
From TriSalus Life Sciences
Via Business Wire
News headline image
TriSalus Life Sciences to Participate in the Canaccord Genuity 46th Annual Growth Conference
July 29, 2026
From TriSalus Life Sciences
Via Business Wire
News headline image
TriSalus Life Sciences to Host Second Quarter 2026 Financial Results Conference Call
July 16, 2026
From TriSalus Life Sciences
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI
June 23, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm
June 17, 2026
From Schall Law
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI
June 16, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm
June 10, 2026
From Schall Law
Via GlobeNewswire
News headline image
TriSalus Life Sciences to Host Virtual KOL Event on June 24 Featuring New Real-World Evidence for Pressure-Enabled Drug Delivery™ in Liver Cancer
June 10, 2026
From TriSalus Life Sciences
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI
June 09, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm
June 03, 2026
From The Schall Law Firm
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI
June 02, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Securities Fraud Investigation Into TriSalus Life Sciences Inc. (TLSI) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
May 20, 2026
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
TriSalus Life Sciences Inc. (TLSI) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
May 20, 2026
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
TLSI Investor Alert: Levi & Korsinsky Investigates TLSI (TLSI) for Potential Securities Fraud
May 19, 2026
From Levi & Korsinsky, LLP
Via Business Wire
News headline image
Securities Fraud Investigation Into TriSalus Life Sciences Inc. (TLSI) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
May 19, 2026
From The Law Offices of Frank R. Cruz
Via Business Wire
In today's session, these stocks are experiencing unusual volume. ↗
May 19, 2026
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
May 19, 2026
Via Chartmill
News headline image
TriSalus (TLSI) Q1 2026 Earnings Transcript ↗
May 14, 2026
Via The Motley Fool
Wednesday's session: top gainers and losers ↗
May 13, 2026
Via Chartmill

Frequently Asked Questions

Is TriSalus Life Sciences, Inc. - Common Stock publicly traded?
Yes, TriSalus Life Sciences, Inc. - Common Stock is publicly traded.
What exchange does TriSalus Life Sciences, Inc. - Common Stock trade on?
TriSalus Life Sciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for TriSalus Life Sciences, Inc. - Common Stock?
The ticker symbol for TriSalus Life Sciences, Inc. - Common Stock is TLSI on the Nasdaq Stock Market
What is the current price of TriSalus Life Sciences, Inc. - Common Stock?
The current price of TriSalus Life Sciences, Inc. - Common Stock is 3.630
When was TriSalus Life Sciences, Inc. - Common Stock last traded?
The last trade of TriSalus Life Sciences, Inc. - Common Stock was at 10/16/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap